Log In
Print this Print this

cariprazine (MP-214, RGH-188)

  Manage Alerts
Collapse Summary General Information
Company Gedeon Richter Ltd.
DescriptionPartial agonist of the dopamine D3 and D2 receptors
Molecular Target Dopamine D3 receptor (DRD3) ; Dopamine D2 receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today